Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

SELL
$25.32 - $51.45 $223,069 - $453,274
-8,810 Reduced 49.37%
9,034 $331,000
Q3 2022

Nov 14, 2022

BUY
$46.5 - $79.14 $25,342 - $43,131
545 Added 3.15%
17,844 $842,000
Q2 2022

Aug 08, 2022

BUY
$63.06 - $84.75 $21,251 - $28,560
337 Added 1.99%
17,299 $1.24 Million
Q1 2022

May 12, 2022

SELL
$74.15 - $99.36 $225,860 - $302,650
-3,046 Reduced 15.22%
16,962 $1.37 Million
Q4 2021

Feb 02, 2022

SELL
$86.01 - $102.89 $410,267 - $490,785
-4,770 Reduced 19.25%
20,008 $2.05 Million
Q3 2021

Nov 12, 2021

SELL
$84.7 - $96.31 $74,620 - $84,849
-881 Reduced 3.43%
24,778 $2.17 Million
Q2 2021

Aug 03, 2021

BUY
$76.44 - $89.57 $366,606 - $429,577
4,796 Added 22.99%
25,659 $2.3 Million
Q1 2021

May 17, 2021

BUY
$67.36 - $80.76 $88,308 - $105,876
1,311 Added 6.71%
20,863 $1.58 Million
Q4 2020

Feb 11, 2021

BUY
$53.08 - $69.86 $271,185 - $356,914
5,109 Added 35.37%
19,552 $1.33 Million
Q3 2020

Nov 13, 2020

BUY
$51.29 - $65.09 $118,479 - $150,357
2,310 Added 19.04%
14,443 $768,000
Q2 2020

Aug 11, 2020

BUY
$34.32 - $62.43 $285,199 - $518,793
8,310 Added 217.37%
12,133 $706,000
Q1 2020

May 08, 2020

SELL
$32.64 - $73.63 $6,854 - $15,462
-210 Reduced 5.21%
3,823 $151,000
Q4 2019

Feb 07, 2020

BUY
$48.0 - $59.55 $17,712 - $21,973
369 Added 10.07%
4,033 $240,000
Q3 2019

Oct 31, 2019

BUY
$46.64 - $55.39 $16,324 - $19,386
350 Added 10.56%
3,664 $195,000
Q2 2019

Aug 09, 2019

BUY
$40.81 - $52.42 $61,623 - $79,154
1,510 Added 83.7%
3,314 $170,000
Q1 2019

Apr 24, 2019

BUY
$36.91 - $55.7 $4,761 - $7,185
129 Added 7.7%
1,804 $93,000
Q4 2018

Jan 30, 2019

BUY
$36.49 - $51.72 $61,120 - $86,631
1,675 New
1,675 $66,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.